Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 119,626Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4AstraZeneca Canada Inc.

02 1Bereskin & Parr LLP

03 3Smart & Biggar LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
CPHI Shenzhen
Not Confirmed
arrow
CPHI Shenzhen
Not Confirmed

Roflumilast

Brand Name : DAXAS

Patent Number : 2475923

Filing Date : 2003-02-19

Strength per Unit : 500?g

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-02-19

Date Granted : 2013-06-18

blank

02

arrow
CPHI Shenzhen
Not Confirmed
arrow
CPHI Shenzhen
Not Confirmed

Roflumilast

Brand Name : DAXAS

Patent Number : 2165192

Filing Date : 1994-07-02

Strength per Unit : 500?g

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-07-02

Date Granted : 2001-04-24

blank

03

arrow
CPHI Shenzhen
Not Confirmed
arrow
CPHI Shenzhen
Not Confirmed

Roflumilast

Brand Name : DAXAS

Patent Number : 2506962

Filing Date : 2003-11-26

Strength per Unit : 500?g

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-11-26

Date Granted : 2012-01-03

blank

04

arrow
CPHI Shenzhen
Not Confirmed
arrow
CPHI Shenzhen
Not Confirmed

Roflumilast

Brand Name : DAXAS

Patent Number : 2506956

Filing Date : 2003-11-26

Strength per Unit : 500?g

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-11-26

Date Granted : 2012-10-02

blank

05

Bereskin & Parr LLP

arrow
CPHI Shenzhen
Not Confirmed

Bereskin & Parr LLP

Country
arrow
CPHI Shenzhen
Not Confirmed

ROFLUMILAST

Brand Name : ZORYVE

Patent Number : 3006836

Filing Date : 2018-05-31

Strength per Unit : 0.3% w / w

Dosage Form : CREAM

Human Or VET : Human

Route of Administration : TOPICAL

Patent Expiration Date : 2038-05-31

Date Granted : 2019-06-11

blank

06

Smart & Biggar LLP

arrow
CPHI Shenzhen
Not Confirmed

Smart & Biggar LLP

Country
arrow
CPHI Shenzhen
Not Confirmed

ROFLUMILAST

Brand Name : ZORYVE

Patent Number : 3006836

Filing Date : 2018-05-31

Strength per Unit : 0.3% W / W

Dosage Form : FOAM

Human Or VET : Human

Route of Administration : TOPICAL

Patent Expiration Date : 1938-05-31

Date Granted : 2019-06-11

blank

07

Smart & Biggar LLP

arrow
CPHI Shenzhen
Not Confirmed

Smart & Biggar LLP

Country
arrow
CPHI Shenzhen
Not Confirmed

ROFLUMILAST

Brand Name : ZORYVE

Patent Number : 3162675

Filing Date : 2021-12-03

Strength per Unit : 0.3% W / W

Dosage Form : FOAM

Human Or VET : Human

Route of Administration : TOPICAL

Patent Expiration Date : 1941-12-03

Date Granted : 2023-09-26

blank

08

Smart & Biggar LLP

arrow
CPHI Shenzhen
Not Confirmed

Smart & Biggar LLP

Country
arrow
CPHI Shenzhen
Not Confirmed

ROFLUMILAST

Brand Name : ZORYVE

Patent Number : 3006836

Filing Date : 2018-05-31

Strength per Unit : 0.15% w / w

Dosage Form : CREAM

Human Or VET : Human

Route of Administration : TOPICAL

Patent Expiration Date : 1938-05-31

Date Granted : 2019-06-11

blank